Clinician and service user perceptions of implementing contingency management: A focus group study  by Sinclair, J.M.A. et al.
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Background:  Contingency  management  (CM),  despite  the  evidence  base  for  its effectiveness,  remains
controversial,  with  sub-optimal  implementation.  In  2007,  UK  guidelines  recommended  the  use of  CM  in
publicly funded  services,  but uptake  has  also  been  minimal.  Previous  surveys  of  service  providers  suggest
differences  in  opinions  about  CM, but to date  there  has  been  no  published  involvement  of  service  users
in  this  debate.
Method:  Focus  group  methodology  was  used  to  explore  systematically  the  attitudes,  concerns  and  opin-
ions  of  staff  and  service  users  about  the  use  of  CM,  in  publicly  funded  substance  misuse  services,  to  identify
the key  areas  that  may  be  inﬂuential  in  terms  of implementation  and outcome.  Data  were  analysed
thematically  using  the  constant  comparative  method.
Results:  70  staff  and  service  users  participated  in  9 focus  groups.  15  themes  of discussion  around  CM
were  identiﬁed,  grouped  into  four  categories:  how  CM  was  aligned  to  the  philosophy  of  substance  misuse
services;  the practicalities  of  implementation;  wider  ethical  concerns;  and  how  participants  perceived
the  evidence  for  effectiveness.
Conclusions:  Robust  process  evaluation  in  different  treatment  systems  is needed  to  deﬁne  the  active
components  of CM  for  implementation.  Involvement  of  service  users  in this  process  is  essential  and  is
likely to  provide  valuable  insights  into  the mechanism  of  action  of  CM  and  its  effectiveness  and  uptake
within  complex  treatment  systems.. Introduction
Contingency management (CM) is the term for a range of
ehavioural interventions in which tangible positive rewards are
rovided to individuals contingent upon objective evidence of
ehavioural change. There is a well established evidence base (pri-
arily from US treatment centres) for the effectiveness of CM as
art of a treatment package for people with substance use disor-
ers (Dutra et al., 2008; Plebani Lussier et al., 2006; Prendergast
t al., 2006).
However, speciﬁc differences between UK and US health and
elfare systems mean that there is likely to be signiﬁcant differ-
nces in the cost-effectiveness of CM interventions depending on
hether a service user, provider or societal perspective is taken.
ithin the UK, health and social care is ﬁnanced through general
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taxation to provide universal coverage, which is free at the point of
delivery to the patient. This means that the beneﬁts of CM are most
likely to be found at a societal perspective, as indeed has been the
case with other substance misuse programme (Gossop et al., 2001).
In the US, where most of the CM research has been undertaken
(Dutra et al., 2008; Pilling et al., 2007) differences in incremental
cost effectiveness ratios (ICERs) even between individual sites in
multicentre research programmes suggest that treatment delivery
factors and variability in patient groups may  make a real difference
to the cost-effectiveness of CM at an individual and provider level
(Olmstead et al., 2007).
Surveys of treatment providers in the US (Benishek et al., 2010;
Kirby et al., 2006; McGovern et al., 2004) and a qualitative study
from Australia (Cameron and Ritter, 2007) show that a number
of factors inﬂuence practitioner attitudes to CM,  and their like-
lihood of adopting it as a treatment. These include practitioner
understanding of the evidence base, the practicalities of imple-
Open access under CC BY license. menting it, as well as the socio-demographic characteristics of
the practitioners themselves, and how these might differ within
teams, and between practitioners and management (Kirby et al.,
2006). The effectiveness of a single behavioural intervention for
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Table  1
Summary of the principles of Contingency Management from UK guidelines 2007.
Contingency management aimed at reducing illicit drug use for people receiving methadone maintenance treatment or who primarily misuse stimulants should be
based  on the following principles:
• The programme should offer incentives (usually vouchers that can be exchanged for goods or services of the service user’s choice, or privileges such as take-home
methadone doses) contingent on each presentation of a drug-negative test (for example, free from cocaine or non-prescribed opioids)
•  The frequency of screening should be set at three tests per week for the ﬁrst 3 weeks, two  tests per week for the next 3 weeks, and one per week thereafter until
stability  is achieved
• If vouchers are used, they should have monetary values that start in the region of £2 and increase with each additional, continuous period of abstinence
•  Urinalysis should be the preferred method of testing but oral ﬂuid tests may  be considered as an alternative
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aef.: National Institute for Health and Clinical Excellence (2007).
ny chronic medical condition including addictions is likely to be
ffected by multiple contextual factors including national health
olicies, funding priorities, individual and institutional views on
he role of the state, and the responsibility of the individual in
odifying behaviour. To date there have been no published stud-
es from the UK of practitioners’ or service users’ understanding
f and attitudes towards CM within the UK substance misuse ser-
ices, which may  further illuminate the processes involved in the
ptake of complex and contentious interventions of this kind across
ifferent health systems.
In the UK, the national treatment guidelines on psychosocial
nterventions for drug misuse (National Institute for Health and
linical Excellence, 2007) recommended the introduction of CM
nto UK drug treatment services, based on the international evi-
ence, although recognising the paucity of evidence within the UK.
raining of clinicians and improving public understanding of the
eneﬁts of using CM in substance misuse services were seen as
mportant and necessary steps to be overcome for effective imple-
entation to occur (Pilling et al., 2007). Other than a number of
demonstration sites’ that have not published their ﬁndings, there
as been no systematic implementation of CM in the UK.
The aim of this study was to explore systematically the atti-
udes, concerns and opinions of staff and service users about the use
f CM,  as detailed by National Guidelines (Department of Health,
007; National Institute for Health and Clinical Excellence, 2007), in
ublicly funded substance misuse services (see Table 1). As there is
o previous published data in this area, qualitative methods (focus
roups) (Kitzinger, 1995) were used to deﬁne key areas, and allow
or the identiﬁcation of factors and processes that may  be inﬂuential
n terms of implementation and outcome.
. Method
.1. Participants and procedures
Focus groups were conducted to explore participant attitudes
nd opinions about the implementation of CM.  Purposive sampling
as used to include key stakeholders using and working in and with
ublicly-funded specialist substance misuse services. Staff and ser-
ice users from specialist substance misuse services were recruited
o one of nine focus groups.
Specialist addiction psychiatrists were identiﬁed through atten-
ance at one of two Specialist Clinical Addiction Network (SCAN)
onferences. An information sheet was sent out to delegates before
ach conference to invite them to take part in a focus group. For the
ecruitment of other staff, we approached four specialist substance
isuse teams, two within East London (an area of high urban depri-
ation) and two within Hampshire, a mixed rural and urban area.
ecruitment of staff was through the team manager. Service users
ere approached by staff and/or team managers working in spe-
ialist substance misuse services to participate in one of two  focus
roups, whilst a third group were recruited through their links with
 voluntary service user advocacy group.2.2. Data collection
Focus groups were conducted between May  2008 and 2009.
Each group lasted approximately 1 h and consisted of between two
and 12 people. All groups were conducted by a facilitator and co-
facilitator, audio digitally recorded and transcribed verbatim. All
followed the same procedure. After participants introduced them-
selves, the facilitator read a pre-written summary of the principles
of CM as proposed by the NICE Guideline ‘Drug misuse: psy-
chosocial interventions’ (National Institute for Health and Clinical
Excellence, 2007). Participants were asked to discuss their ini-
tial thoughts on the guideline with each other for approximately
15 min, before being given three brief clinical vignettes to explore.
Each vignette described a scenario for which recommendations
were made in the NICE Guidelines (substitute prescribing for opiate
dependence, cocaine misuse, completion of immunization pro-
gramme  for Hepatitis B). The vignettes are presented in Fig. 1.
After each vignette was presented, the group were asked to discuss
whether a client should be offered incentives in the given situation,
and the reasoning behind their opinions.
2.3. Data analysis
Data collection and analysis occurred simultaneously using ana-
lytic techniques of the constant comparative method (Glaser, 1992;
Glaser and Strauss, 1967). All transcripts were read and corrected by
the facilitator and co-facilitator of each group, and annotated with
ﬁeld notes taken by the co-facilitator during the group, to ensure
that the context of what was said, and other social cues, (e.g., laugh-
ter, murmured agreement, etc.) was retained. Transcripts and the
associated annotations were imported into the qualitative software
package NVivo7 (QSR International Pty Ltd., 2006) to aid analy-
sis. Three of the researchers (JS, AB, SP) read the transcripts and
independently deﬁned a preliminary coding scheme which was
discussed in the research team. The ﬁnal coding scheme was gen-
erated by an iterative process as further data were collected until
saturation was  reached. Data were coded by AB independently
reading the transcripts and coding all material using NVivo7 (QSR
International Pty Ltd., 2006) software, with continuous compari-
son and discussion where discrepancies arose. The research team
discussed and analysed the link between the early dense codes and
broader themes to ensure conceptual clarity and consistency across
the themes and further recoding where required.
3. Results
3.1. Participants
A total of nine focus groups were carried out, consisting of: cur-
rent service users (2 groups: N = 2, N = 6), ex service users (1 group:
N = 6), specialist addiction psychiatrists (2 groups: N = 9, N = 11) and
multidisciplinary staff teams working in publicly-funded special-
ist substance misuse services (4 groups: N = 9, N = 7, N = 10, N = 10).
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Focus Group  Vignette  1 
Client in service for opiate  misuse for six months. Stabilised on 90 mg  methadone, daily 
pick-up. Urines continue to show use of heroin and crack. No complaints of opiate 
withdrawal,  but  finding it  difficult  to  stop habits  associated with illi cit su bstance u se. 
 
Should this  client be offered incentives to produce clean urine samples? 
 
 
Focus Group  Vignette  2 
Client attends service for use of cocaine.  Injecting daily and engaging  in  risky  and 
criminal be haviors.  Recognises  the difficulties  that the  behaviour is cau sing to partner and 
family and wanting to stop, but finds it difficult  to  maintain  motivation  between  sessions 
 
Should this  client be offered incentives to produce clean urine samples? 
 
 
Focus Group  Vignette  3 
Client  with polysubstance misuse  and injecting daily.  Very  chaotic  li festyle  and  fre quently 
engages in unprotected sex.  Understands possibilities o f transmiss ion of he patitis  and 
happy to  have  Hepatitis  B testing and immunization. Has test for Hep B during 
appointment, but then does not attend for follow up. 
 
Should this client be offered incentives to attend for  the completi on of the immunization 
programme? 
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verall, there were 70 participants, including: 14 current or ex-
ervice users (patients), 20 addiction psychiatrists, and 36 staff
orking in multi disciplinary specialist substance misuse teams.
he sample captured a range of experience of staff with the mean
ength of service being 10 years (varying from 10 months to 41
ears). Service users had been using substance misuse services for
n average of 14 years (ranging from three to 36 years). Participants
ere aged between 22 and 62 (mean age 45 years old) and 66% of
he sample was male.
.2. Main themes emerging from focus groups
Although the different groups varied substantially in their com-
osition, which resulted in different levels of discourse, and focus
round the subject, there was a high level of saturation across the
roups in terms of the themes which emerged. In most areas there
ere substantially similar views expressed by the professional
nd service users; areas of disagreement or different emphasis are
ighlighted where these occurred. The ﬁnal agreed coding scheme
ontained a total of 40 codes which were applied consistently
cross all the group transcripts. On review of the content of these
odes, they could then be consolidated into 15 main themes, pre-
ented here under four broad categories (see Fig. 2), with illustrative
xamples given in Table 2.
.3. Philosophy of substance misuses treatment and services (see
able 2.1 for examples)
All 9 of the groups spent some time discussing the role of CM
nd where it ‘ﬁtted’ within current treatment principles. Concern
as expressed from the professional groups that it reintroduced
 more ‘paternalistic’ approach to treatment that had been moved
way from in recent years in the UK. Discussion on the potential
mpact it might have on damaging any intrinsic motivation of the
ervice user to engage with treatment was a particular feature from
hose who were now themselves ‘in recovery.’ There was also much
ebate about how the focus of many services is currently on ‘harm
inimisation’ (e.g., needle exchange, immunisation, maintenance
ubstitute prescribing, etc.) rather than on abstinence and recov-late focus group discussion.
ery. Consequently, the aim of CM to produce drug free urine (see
vignette 1, Fig. 2) did not sit comfortably with this.
Seven groups acknowledged the powerful function of sim-
ple behavioural measures in shaping and changing behaviour
in everyone’s life, as well as the importance of ‘rewarding’
people, especially those with so little that was  positive and
reinforcing in their lives. However, the counter view was also
proposed, that relatively small monetary values might rein-
force peoples’ sense of lack of worth, whereas rewarding them
with a non-monetary incentive tailored speciﬁcally to them
(e.g., access to training, etc.) might be more beneﬁcial. It is
of interest that the two groups of service users currently
within the treatment system did not discuss this aspect of
CM.
There were differences across the groups as to whether CM
as deﬁned in the guidelines represented a form of coercion or
whether it was a treatment incentive. Practitioners were divided
as to whether take home methadone treatment was one of a range
of evidence based therapeutic options available to the clinician (see
below), or something more politically driven. If the latter, it ﬁtted
their broader concerns about the nature of society (e.g., seeing CM
as part of a politically driven policy and the role of the state in peo-
ples lives) which are part of their identity as a citizen, rather than
as a health practitioner, and are therefore ﬁrmly held and not easily
amenable to change (see Section 3.5 below).
As with the other aspects concerning the theories and mecha-
nisms around CM,  its use as one of the several therapeutic options
was  not really discussed by those still in treatment, but was a com-
mon  and recurring theme across all other groups, particularly the
ex-service user group. There was  a general consensus that (if there
was  evidence of effectiveness), the use of CM in principle might be
a useful addition to the therapeutic armamentarium. This idea was
most positively endorsed by those in the professional groups with
greatest experience and training. However, there was a range of
views expressed: from unequivocal beneﬁt, through to a more cau-
tious acceptance of it. Concerns were raised that in a system with
limited resources it may be seen as a cost saving alternative, replac-
ing established and more valued interventions (e.g., time with a
member of staff) and therefore best kept as a ‘last resort’.
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Table  2
Quotations from focus groups illustrating themes from Fig. 2.
1.  Philosophy  of  substance  misuse  treatment  and  services
Recovery  models  and  cycle  of  change
Until  the  individual  user  wants  to  stop  and  wants  to  adhere  to  the  treatment  programme  from  inside  themselves  and  not  just  as  a  sort  of  tick  box  exercise  almost,  or  as  going
through the  motions  then  no  incentive  is  going  to  particularly  work,  it  has  got  to  come  from  within  (Ex-service  user  group)
I think  that  is  a  really  blurred  role  and  this  is  one  of  my  more  fundamental  ethical  objections  with  this  idea  is  that  we  as  clinicians  should  be  providing  people  with
information for  them  to  make  informed  choices,  the  moment  we  start  offering  ﬁnancial  incentives  we  then  undermine  our  role  in  doing  that,  we  are  saying  well  actually
now we  know  what’s  better  for  you  and  you  start  to  adopt  a  more  paternalistic  attitude  (Multidisciplinary  specialist  team  staff)
Is this  abstinence  or  harm  minimisation,  as  far  as  I  understand  we  work  towards  harm  minimisation  with  the  option  of  abstinence,  whereas  this  would  be  making  quite  a
large statement  about  abstinence  as  the  way  forward  and  that  is  not  our  decision  to  make,  it  is  the  client’s  decision  (Multidisciplinary  specialist  team  staff)
Behavioural model
It does  work  quite  well  as  part  of  a  behavioural  therapy,  maybe  an  ABC  sort  of  type,  where  you’ve  looked  at  the  antecedents  of  behaviour,  I’ll  get  my  beneﬁts,  then  I  want
crack, I  therefore  use  crack,  the  consequences  are  I  feel  miserable,  .  .  .  another  consequence  you  could  put  in  to  that  is  “I  don’t  use  I  get  my  voucher”  so  .  .  .  it’s  a  behavioural
treatment anyway  isn’t  it?  (Multidisciplinary  specialist  team  staff)
And it  is  interesting  because  there  are,  dare  I  say  it,  doctors  who  will  sit  down  with  a  drug  rep  and  be  quite  happy  that  they’ve  been  given  a  pen  and  there  is  something  about
the symbolic  nature  of  giving  something  which  is  of  very  small  monetary  value,  which  is  just  about  some  kind  of  token  appreciation  (Specialist  addiction  psychiatrists)
Yeah that  sort  of  material  support  (putting  credit  in  the  electricity  meter)  does  make  a  big  difference  to  any  stage  of  recovery  but  certainly  to  the  early  stages  because  if
you’re giving  up  something  nice,  and  lets  face  it  we  use  because  it  gives  us  a  buzz,  if  you’re  giving  that  buzz  up  you  want  to  see  some  sort  of  payback,  you  don’t  want  to
give up  using  and  ﬁnd  that  you’re  in  a  freezing  ﬂat  (Service  user  advocacy  group)
Existing  forms  of  coercion/incentives  within  treatment
I personally  think  we  already  have  CM  but  we  call  it  a  letter  to  social  services,  a  letter  to  the  magistrate.  How  many  people  come  in  to  services  because  they  don’t  want  to
lose their  kids,  they  don’t  want  to  lose  their  job  or  they  want  to  get  a  ﬂat,  you  know  we  already  have  contingency  management  (Service  user  advocacy  group)
Contingency management  as  ‘part  of  a  toolkit’
I think  it  would  be  really  interesting  to  have  this  as  an  option,  because  we  have  a  number  of  options  at  the  moment  to  explore  with  a  patient  like  this  but  they’re  fairly
limited aren’t  they,  if  there  is  another  option  which  we  may  have  some  discomfort  about  how  it  would  work  in  our  clinic  but  there  is  an  evidence  base  and  it’s  a  bigger
menu to  choose  from  and  to  discuss  with  the  patient.  (Specialist  addiction  psychiatrists)
My fear  with  all  these  contingency  management  programmes  is  they  are  (a)  substitute  for  effective  treatment  and  they  will  become  the  measure  by  which  you  are  assessed,
(that) it  will  be  used  instead  of  the  services  providing  good  motivational  techniques,  good  key  working,  good  care  planning,  it  will  simply  be  how  are  you  doing  on  your
contingency management  and  that  will  be  the  only  measure  of  how  you  are  doing  (Service  user  advocacy  group)
2. Practicalities  and  impact  on  service  provision
Practicalities  of  implementation
I  just  wonder  about  the  initial  two  pounds  for  vouchers,  whether  that’s  really  enough  to  get  a  patient  to  come  to  the  clinic  three  times  a  week  initially  and  then  the  other
issue is  that  (the  vignette)  says  that  it  keeps  increasing  so  how  long  do  you  continue  doing  it?  Are  (patients)  coming  along  and  will  (they)  be  getting  ten  pounds  or  twenty
pounds? (Specialist  addiction  psychiatrists)
For three  urine  samples  a  week  you  know  the  incentive  just  isn’t  there  .  .  ., given  the  amount  of  money  I’d  be  looking  at  spending  on  what  I  was  doing.  .  .  .  the  monetary  value
(£2)  I  wouldn’t  get  out  of  bed  for,  let  alone  stay  sane  (Service  user  group)
Contingency  management  is  a  complex  well  thought  out  psychological  and  principled  matter,  how  would  this  package  be  introduced  and  withdrawn?  How  do  I  introduce
this to  a  client?  How  do  I  introduce  it  with  psychological  principles?  They  are  rewarded  appropriately,  that  is  then  withdrawn  within  the  package,  appropriately?  Those
are big  questions,  not  answered  in  the  UK  as  yet  (Multidisciplinary  specialist  team  staff)
Opportunity  cost
Do  we  know  whether  this  incentive  would  attract  any  extra  funding  because  we  don’t  have  the  staff  to  be  offering  to  see  clients  (to  be  urine  tested)  three  times  a  week?
(Multidisciplinary specialist  team  staff)
Equity
I just  feel  that  everyone  should  be  treated  equally,  and  whereas  discriminating  against  somebody,  it  should  be  for  all  or  none  (Multidisciplinary  specialist  team  staff)
I think  it  should  be  based  on  the  individual  service  user  as  opposed  to  the  mass  (Service  users)
Perverse incentive
If  you  are  trying  to  target  people  who  were  poor  at  attending  and  saying  “we  will  reward  you  to  come  along”,  it  is  an  incentive  to  all  the  others  to  establish  themselves  as  a
non-adherer to  get  on  to  that  scheme  (Multidisciplinary  specialist  team  staff)
Impact on  therapeutic  relationship
My  other  regret  is  that  we  spend  so  much  time  watching  them  pee  and  testing  their  urines  and  talking  about  those  urine  results  is  there  will  be  no  time  left  to  actually
engage with  patients,  and  think  about  why  they  use  drugs  at  all  (Specialist  addiction  psychiatrists)
It might  have  actually  got  me  through  the  door  in  the  early  days  until  those  therapeutic  alliances  were  developed  and  all  the  motivational  stuff  was  getting  me  to  come  back
because it  was  working  for  me.  It  would  have  been  a  good  hook.  It  wouldn’t  have  kept  me  in  treatment,  I  don’t  think,  but  it  might  have  helped  me  during  the  early  days  to
actually engage  properly  (Service  user  group)
I think  it  cheapens  the  work  that  we  are  actually  doing  because  you  know  we  hope  that  we  are  making  some  input  into  making  people  change  and  that  is  down  to  the  way
(we) work  with  them,  not  giving  them  a  prize  for  coming,  giving  them  a  goody  bag  for  turning  up,  its  because  of  what  happens  in  the  intervention  when  they  are  seeing  us
(Multidisciplinary specialist  team  staff)
3. Wider  ethical  concerns
Public  perception:  fears  about  increasing  stigma  towards  addicts
I don’t  think  that  anything  would  be  politically  acceptable  to  [tabloid  newspaper]  readers,  but  giving  someone  heat  and  light  might  be  slightly  more  acceptable  than  giving
them the  money  to  go  and  score  again  (Service  user  advocacy  group)
Its’ not  likely  to  work  in  people  that  have  a  lot  of  money,  so  does  that  stigmatise  the  people  we  are  working  with  because  (those)  we’re  tempting  fall  into  a  very  poor  sub  group
of society?  (Multidisciplinary  specialist  team  staff)
If the  government  feels  it  is  that  important  in  terms  of  the  public  health  need,  to  do  something  different,  then  let  them  apply  it  across  the  board  in  terms  of  incentivising
everyone to  have  the  hepatitis  immunisation,  it’s  not  what  we  as  health  workers  I  think  should  be  doing,  but  if  the  government’s  choosing  to  do  that  because  they  believe
that’s the  only  way  to  address  the  problem  then,  that’s  their  choice  (Multidisciplinary  specialist  team  staff)
Use to  which  incentive  is  put  (Alternative  incentives  to  money  seen  as  positive)
It could  help  some  people,  but  then  a  lot  of  people  would  just  abuse  it  and  come  in  and  like  I  said  it’d  go  towards  the  next  pipe,  so  in  that  sense  it  will  be  bad  because  you’re
encouraging them  to  use  rock  (Service  user  group)
Societal  vs  individual  factors
It’s a  totally  different  scenario  (referring  to  the  Hepatitis  B  vaccination  vignette),  because  it’s  about  other  people,  it’s  about  the  public,  it’s  not  about  the  patient  at  all,  it’s
because you  may  be  helping  the  public  by  immunising  this  man  because  you  don’t  want  him  to  spread  hepatitis  B,  so  it’s  an  incentive,  it’s  a  public  health  incentive  I  think
(Multidisciplinary specialist  team  staff)
I can  really  see  the  sense  of  rewarding  people  to  have  their  vaccinations,  and  I  think  that’s  a  win-win  situation  (Multidisciplinary  specialist  team  staff)
when you’re  a  sex  worker  .  .  . you’ve  got  kids  to  think  of,  they’ve  got  to  go  home  to  their  wife,  you  know,  it’s  just  a  vicious  circle”  (Service  user  group)
4. Evidence  of  effectiveness
If the  reason  why  it’s  been  promoted  is  because  of  the  evidence  base  ok,  it’s  in  America  so  be  it,  but  nevertheless  there  is  evidence  that  it  works,  so  from  a  pragmatic  point,
our job  is  to  support  people  to  stop  using  drugs  as  far  as  I’m  concerned.  (Multidisciplinary  specialist  team  staff)
Critically might  there  be  nuances  that  would  make  what  happens  in  Idaho  not  completely  replicable  in  Mansﬁeld?  (Specialist  addiction  psychiatrist)
Just because  something  works  should  we  be  using  it  at  all?  And  I  think  we’ve  skipped  the  ﬁrst  part  a  bit,  you  know  all  sorts  of  things  work  but  I don’t  remember  them  all
being acceptable  so,  .  .  .  just  because  it  works  doesn’t  mean  its  good  to  my  mind  (Specialist  addiction  psychiatrist)
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Patients and ex 
patients (Advocates) 
(3 groups, N=14, 
M:F  11:3) 
Multi disciplina ry 
Specialist Addiction 
Team Staff (4 groups, 
N=35 M:F 19:16) 
Specialist Addiction 
Psychiatrists  
(2 groups, N=21 
M:F 16:5) 
 Equity (6) 
 
Opportunity cost (4) 
 
 Practic alities (8)  
Behavioural model  (7) 
 
Existing forms of coercion/ treat ment 
(5) 
Recovery model and cycle of change 
(9) 
Perv ers e incenti ve (6)  
 
Philosophy of 
Addictions 
Treatment 
Services 
Impact  on  therapeutic  relationship (5)  
Evidence of 
Effectiveness 
 
Practicalities and 
Impact on Service 
Provision 
 
Wider Ethical 
Concerns 
For whose benefit: public or patient 
(8) 
Concerns about specificity to 
addiction treatment - why not other 
conditions (7) 
Ethical concerns (6) 
Public perception;  concerns  about  it 
increasing stigma of addictions (6)  
Part of thera peutic  ‘to olkit’  (7)  
Use to which incentive is put (9) 
 
FOCUS GROUPS                                 CATEGOR IES                               THEMES AND FREQUEN CIES (n =grou ps)             
(9 groups with 70  
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Much of the discussions of aspects of treatment delivery are
ommon to other aspects of health care where incentives are used
s part of treatment. They were framed within the concepts of
ealth economics and medical ethics and included the follow-
ng ﬁve themes: practicalities of implementation; the opportunity
osts of the intervention; the possibility of CM acting as a per-
erse incentive; issues of equity; and the potential impact on the
herapeutic relationship (see Fig. 2 and Table 2.1).
The practicalities and potential problems of implementation
as a major theme across all but one focus group (service users)
nd included aspects that would be anticipated from any dis-
ussion about change management. However, concerns were also
xpressed that were more speciﬁc to implementing a behavioural
ntervention, where it is well recognised that the precise details are
ntegral to the effectiveness of the implementation, and the possi-
ility of unintended consequences. Regarding the implementation
f CM within a publicly funded system, participants in four groups
3 professional groups and the ex-service user group) expressed
oncerns about the opportunity cost of such a change of focus. All
ine groups expressed concerns about the feasibility of the level of
rine testing (three times per week). However, whilst the profes-
ional teams viewed this as being resource heavy and had concerns
bout the potential opportunity costs of delivery (see Table 2.1),es, emerging themes.
the service user groups felt strongly that such a regime acted as
a disincentive that would outweigh any beneﬁt from the ﬁnancial
incentive offered.
Concerns about the notion of equity of access to interventions
within the treatment system, and that CM might act to incentivise
non-engagement (i.e., act as a perverse incentive) were discussed in
6/9 groups. Concerns about equity were primarily expressed in the
professional groups. Service user groups felt it more appropriate
for CM to be offered on an individual basis depending on the needs
of the service user at a particular time, rather than being mandated
to particular groups and certain points in their treatment journey.
They speciﬁcally felt that it may  be more helpful as an initial incen-
tive to encourage people to attend services for assessment rather
than once they were already engaged with services as suggested in
the guidelines.
Finally, within this category was  a discussion around the
potential for CM to have a negative impact on the therapeu-
tic relationship, as time could be spent reviewing (and arguing
about) urine samples rather than discussing the treatment needs
of the service user. Some of the multi-disciplinary team members
expressed the view that acting as a ‘broker’ within a CM system
where the result of a test had pre conditioned consequences ‘cheap-
ened’ the work that they did. There was  no mention in any group
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hat implementation of CM per se might enhance the therapeutic
elationship.
.4. Wider ‘ethical concerns’ (see Table 2.3 for examples)
This category encompasses the broader, often less focussed and
ore abstract discussion that the groups held around the general
oncepts of using public money, within a health system that offers
niversal coverage, to incentivise people to change their behaviour.
requently raised concerns across the groups included: whether
he use of CM for people in substance misuse services further stig-
atised this patient group within the public mind? Who  was the
eal beneﬁciary of this kind of intervention – the service users
hemselves or the public at large? Was  this policy being driven by
olitical motivation rather than the evidence base? These discus-
ions articulated concerns of moral principle and personal belief,
hich were not evidence dependent, were not changeable within
he group discussion or remediable by research or policy clariﬁca-
ions.
One speciﬁc aspect mentioned by all 9 groups was  the use to
hich any ﬁnancial incentive might be put. All recognised the pos-
ibility that it might be misused to buy further drugs, and the ex
ervice user group speciﬁcally mentioned how giving people ‘extra’
oney at a vulnerable point in their treatment pathway may  do
ore harm than good. Whilst issues of autonomy were mentioned,
mall ﬁnancial incentives were seen as being speciﬁcally targeted
t the poorer in society. Whilst any incentive could have a monetary
alue if traded, a common theme across the groups was  that non-
onetary incentives targeted to the person’s particular need (e.g.,
unding for electricity, public transport) may  be more beneﬁcial.
The public versus personal beneﬁt of CM was felt to be particu-
arly relevant in the scenario where service users were incentivised
o complete the full vaccination course for Hepatitis B (see Fig. 1,
ignette 3). This was viewed more as a single ‘harm minimisation’
xercise that offered long term protection to others, and therefore
ith a clear objective and ﬁxed outcome, rather than an as part of
 more complex treatment intervention in its own  right. Overall,
ven where participants had expressed concerns over using CM as
 means of achieving abstinence in the earlier vignettes, they felt
uch more comfortable with this more circumscribed intervention
hat offered a tangible and sustained positive outcome to both the
rug user and the wider society.
.5. Evidence of effectiveness (9 groups)
There were three main sub-themes that were brought up by
articipants around CM pertaining to the relative importance of
ffectiveness of CM as an intervention. These were as follows (see
able 2.4 for examples):
. A pragmatic approach that linked in with the discussions around
having CM as part of a ‘tool kit’ of interventions. This could be
summarised as ‘if it works, use it.’ This stance was primarily
taken by the more experienced clinicians.
. A critique of whether the evidence base (which was understood
by participants to be primarily from USA treatment centres) may
not necessarily work by the same mechanism or to the same
effect within the UK health and social care system and that cau-
tion was required in assuming direct transposition.
. A ﬁrmly held belief that even if there was evidence of effective-
ness for an intervention, it did not mean that it was  necessarily an
acceptable addition to the treatment system. This was a theme
from across the groups, generally held by a small number of peo-
ple within each group, but expressed ﬁrmly and consistently, and
not appearing amenable to change by the group process. Dependence 119 (2011) 56– 63 61
4. Discussion
The aims of this study were to explore systematically the atti-
tudes, concerns and opinions of staff and service users about the
use of CM in publicly funded substance misuse services and to
identify the key areas that may  be inﬂuential in terms of implemen-
tation and outcome. Below we  summarise the ﬁndings and examine
speciﬁcally what this study adds to the literature in terms of:
1. How CM may  ﬁt within the context of substance misuse pro-
grammes.
2. The concerns about implementation.
3. Broader concerns that might be seen to represent individuals’
beliefs and concerns as a citizen rather than that as patient or
healthcare provider.
The causes of addictions are well recognised to be a complex
interaction of biological, social and psychological factors and from
a health perspective can be considered within a chronic disease
model (McLellan et al., 2000), requiring a collaborative approach
between professional and patient if long-term, sustained positive
outcomes are to be achieved. Many substance misuse services in
developed countries work within a multi-disciplinary, community
treatment model. Consequently, the way that new interventions
are viewed by clinicians (in their role as individual citizen as
well as practitioner), and the collective philosophy of a treatment
service will have a substantial impact on the effectiveness and cost-
effectiveness of their implementation and uptake (Benishek et al.,
2010; Cameron and Ritter, 2007; Kirby et al., 2006; McGovern et al.,
2004).
4.1. What are the key aspects underpinning the discussion about
the role of CM in substance misuse treatment programmes?
This study highlighted the issues most consistently discussed
about the use of CM by service users (both current and past) and
health professionals. The 15 different themes are concerns that
will need to be considered in any evaluation of effectiveness of
CM implementation within different clinical settings, and across
different health care systems.
4.1.1. Role of CM within the philosophy of substance misuse pro-
grammes. Whilst the evidence base from randomised controlled
trials (RCTs) for the role of CM in substance misuse programmes
is compelling (Dutra et al., 2008; National Institute for Health and
Clinical Excellence, 2007; Pilling et al., 2007) the uptake into clin-
ical practice has been less good (Kirby et al., 2006; Petry, 2006).
The results of this study suggest that the overall aims of a treat-
ment programme (e.g., whether the aim is for harm minimisation
or abstinence) may  be a signiﬁcant factor in how a single inter-
vention is viewed and the likelihood of its implementation. The
methodology of an RCT, even of a complex intervention, specif-
ically attempts to insulate the intervention under examination,
from such contextual factors. This study suggests that it is a key
concern for professionals that any single intervention is coher-
ent with the broader goals of the service. In addition to this,
these results add empirical data to suggestions from other authors
(Petry, 2006; Pilling et al., 2007) that the wider societal and polit-
ical values that practitioners and service users hold as citizens
will have an impact on how new interventions are deliveredand media coverage will also affect and be affected by societal
trends at any particular time and have an impact on the percep-
tion and implementation of speciﬁc health policies (Reinhardt,
1990).
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.1.2. Practicalities and impact on service provision. Whilst some of
he discussion of the impact that implementing CM might have
ithin the treatment system could be viewed as an anticipated
esponse to implementing changes in any service and therefore
menable to good change management processes, there are speciﬁc
etails about CM that may  impact on its implementation and effec-
iveness. Our results support the ﬁndings of Kirby et al. (2006), that
taff have concerns about service costs associated with the schedule
f urine tests required, and the need to target more positive treat-
ent outcomes (e.g., improved health and wellbeing) than simply
iming for drug free urines. Our results also suggest that staff and
ervice users felt that the schedule of urine testing was  unreason-
ble and impractical, but could be ‘altered’ to make them more
cceptable, whilst the evidence base (Grifﬁth et al., 2000) shows
hat the frequency of tests is a core component of effectiveness.
his demonstrates one potential mechanism for how effect sizes in
linical trials may  have a different impact once they are adopted
nto routine practice.
Who  should be offered CM was another consistent concern. The
eneral consensus across the professionals was that it should be
vailable to all service users at a particular point in the treatment
ystem, to fulﬁl the principles of horizontal equity (providing equal
ealthcare to those with equal need) (Culyer, 1995) and to stop
 system of perverse incentives being set up (i.e., service users
eing rewarded for non-adherence to treatment). There was also
 concern that CM might potentially damage the therapeutic rela-
ionship. These are common concerns described in the literature
bout the use of ﬁnancial incentives to change health behaviour
cross a range of conditions (Burton et al., 2010; Marteau et al.,
009; Oliver, 2009; Priebe et al., 2010), but one for which there is
urrently limited empirical data. However, the service user groups
n our sample did not express any such concerns; in fact, all three
roups discussed the importance of tailoring a speciﬁc incentive
ﬁnancial or otherwise) only to those who might beneﬁt from it,
uggesting an understanding and acceptance of vertical equity (i.e.,
reating differently those who have different needs) (Culyer, 1995),
s a key factor in ensuring CM was most effective. This service user
erspective has not, as far as we are aware, previously been dis-
ussed in the literature and may  have important implications in
erms of how CM systems are implemented in practice.
.1.3. Broader concerns. There was much discussion within the
rofessionals group about CM being considered as a politically
riven initiative, which was extended to more general feelings of
ntipathy towards treatment guidelines. There is a substantial lit-
rature on the length of time that it takes to get new research
dopted into practice (Benishek et al., 2010; McGovern et al., 2004).
lthough not all the groups were aware of the literature of the
ffectiveness of CM,  there was a general assumption that a liter-
ture existed as the basis of a national guideline. However, as with
ther studies, practitioners were quick to cite that the research evi-
ence did not reﬂect the complexity of the service users or clinical
ituation of routine practice and this affects the perception of its
sefulness for clinical decision making (Miller, 1987; Greenhalgh
t al., 2004; Kirby et al., 2006; Pilling et al., 2007).
.2. Strengths and limitations
The study is limited by the relatively small number of partici-
ants who took part in the focus groups. Issues of generalisability
ave a different focus within qualitative work, in that a study of this
ind seeks to raise awareness of the concepts and deﬁne the phe-
omena to be further reﬁned and tested for prevalence using other
ethods (Craig et al., 2008). The smallest focus group only included
wo female service users (both working as prostitutes) but the rel-
tive privacy of this group allowed for an in-depth exploration of Dependence 119 (2011) 56– 63
the issues that they may  have been less happy to engage with in a
larger group.
One of the strengths of this study is that the use of qualitative
methods allows for a more in-depth and contextualised exploration
of the factors which may  inﬂuence the implementation and effec-
tiveness of a complex intervention such as CM.
Previous studies have shown that there are differences in the
attitudes of staff members to CM (Benishek et al., 2010; Kirby
et al., 2006; McGovern et al., 2004; Petry, 2006) and this study
highlights the complex interaction of professional attributes and
personal beliefs that may  underlie these attitudes. That many of
the concerns about CM appear to be similar in this smaller num-
ber of UK practitioners to the larger US surveys (Benishek et al.,
2010; McGovern et al., 2004) suggests the validity and generalis-
ability of these results, and some common cross cultural themes
that require more robust process evaluation in future RCTs. A ﬁnal
strength of this study is the inclusion of service users within the
analysis, and the different emphasis that they bring to treatment
decision making.
4.3. The role of process evaluation to help elucidate the core
components of CM
There is a growing literature demonstrating the importance of
including process evaluation as an essential part of clinical trials of
complex interventions (Audrey et al., 2006; Craig et al., 2008; Hawe
et al., 2004; Lewin et al., 2009). One suggestion is to standardise the
process of the intervention rather than the components themselves
(Hawe et al., 2004), thus intervention ‘integrity’ would be deﬁned
as the evidence of ﬁt with the principles of the hypothesised change
process (in this case CM)  rather than trying to reproduce the ‘exact’
conditions in each site. In order to do this, the active ingredients
of a complex intervention need to be deﬁned, including delivery
mechanisms (Craig et al., 2008). In psychological interventions the
attitudes of both staff and patients towards the intervention and
their perception of its place within the treatment system, are likely
to be important active ingredients and need further elucidation.
4.4. Implications
CM has been shown to be an effective intervention in the treat-
ment of substance misuse. However, it is controversial and uptake
within treatment systems has not been as widespread as the evi-
dence would warrant.
There is a need for robust process evaluation of CM in different
treatment systems, to deﬁne the active components of the process
and the mechanism by which they are working (Hawe et al., 2004).
Involvement of service users and advocacy groups in this process is
essential and is likely to provide valuable insights into the mecha-
nism of action of CM as well as its effectiveness and uptake within
complex treatment systems.
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